Apogee Therapeutics Inc (NAS:APGE)
$ 134.17 -0.14 (-0.1%) Market Cap: 10.15 Bil Enterprise Value: 9.10 Bil PE Ratio: 0 PB Ratio: 8.00 GF Score: 12/100

Apogee Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 09, 2026 / 03:00PM GMT
Release Date Price: $85 (+2.40%)
Mark McKenna
Apogee Therapeutics Inc - Independent Chairman of the Board

Welcome to the Apogee Therapeutics 2026 Annual Meeting of Shareholders. My name is Mark McKenna, Chairman of Apogee's Board of Directors in today's meeting.

Thank you all for joining us today. Let me begin by introducing your Board of Directors: Dr. Michael Henderson, our Chief Executive Officer; Dr. Lisa Bollinger; Jennifer Fox; William Jones, Jr.; Tomas Kiselak; and Nimish Shah.

I would also like to introduce other members of the management team who are joining us today: Jane Henderson, Chief Financial Officer; Dr. Carl Dambkowski, Chief Medical Officer; Matt Batters, Chief Legal Officer and Corporate Secretary. Representatives of our independent registered public accounting firm, Ernst & Young, are also joining us today.

Matt Batters will serve as Secretary of the meeting, and a representative of the Carideo Group has been appointed Inspector of Elections to examine and count proxies and votes for this meeting.

This meeting will be conducted in accordance with the meeting and rules of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot